Followers | 519 |
Posts | 67213 |
Boards Moderated | 1 |
Alias Born | 06/10/2009 |
Wednesday, March 01, 2023 4:32:43 PM
Clearday Retains ClearThink Capital to Explore Unlocking Value with SPACs
Press Release | 01/26/2023
San Antonio, Texas, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (OTCQX: CLRD), the “Company” or “Clearday” or “we”, retained ClearThink Capital LLC, a boutique investment and transactional advisory firm, to support Clearday’s strategy to explore transactions to unlock the value of its innovative care businesses through a deSPAC transaction.
ClearThink has a team of seasoned finance, investment banking, law, marketing, technology, medical, life science, and operations professionals with extensive experience in structuring and executing, and advising with respect to a range of transactions, including providing guidance to companies engaged in transactions with Special Purpose Acquisition Corporations (SPACs) – a deSPAC, which is one of transaction structures that Clearday believes would unlock the value of its innovative care businesses such as robotic service and digital services.
https://www.otcmarkets.com/stock/CLRD/news/Clearday-Retains-ClearThink-Capital-to-Explore-Unlocking-Value-with-SPACs?id=387784
Recent CLRD News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:35:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:19:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 10:00:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:45:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:15:22 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 10/31/2023 08:42:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 08:30:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 09/14/2023 10:06:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 03:00:11 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:31:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 08:47:16 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM